<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
<journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
<journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
<journal-title-group>
<journal-title>JCI Insight</journal-title>
</journal-title-group>
<issn pub-type="epub">2379-3708</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27699255</article-id>
<article-id pub-id-type="pmc">5033885</article-id>
<article-id pub-id-type="publisher-id">85461</article-id>
<article-id pub-id-type="doi">10.1172/jci.insight.85461</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bagheri</surname>
<given-names>Hani</given-names>
</name>
<email>hani.bagheri@alumni.ubc.ca</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Badduke</surname>
<given-names>Chansonette</given-names>
</name>
<email>charvard@cfri.ca</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qiao</surname>
<given-names>Ying</given-names>
</name>
<email>yqiao@mail.ubc.ca</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Colnaghi</surname>
<given-names>Rita</given-names>
</name>
<email>r.colnaghi@sussex.ac.uk</email>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abramowicz</surname>
<given-names>Iga</given-names>
</name>
<email>I.Abramowicz@sussex.ac.uk</email>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alcantara</surname>
<given-names>Diana</given-names>
</name>
<email>D.R.R.Alcantara@sussex.ac.uk</email>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dunham</surname>
<given-names>Christopher</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wen</surname>
<given-names>Jiadi</given-names>
</name>
<email>Jiadi.Wen@UTSouthwestern.edu</email>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wildin</surname>
<given-names>Robert S.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nowaczyk</surname>
<given-names>Malgorzata J.M.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eichmeyer</surname>
<given-names>Jennifer</given-names>
</name>
<email>eichmeyj@slhs.org</email>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lehman</surname>
<given-names>Anna</given-names>
</name>
<email>ALehman@cw.bc.ca</email>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maranda</surname>
<given-names>Bruno</given-names>
</name>
<email>Bruno.Maranda@USherbrooke.ca</email>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martell</surname>
<given-names>Sally</given-names>
</name>
<email>sally.martell@ubc.ca</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shan</surname>
<given-names>Xianghong</given-names>
</name>
<email>xhshan@mail.ubc.ca</email>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lewis</surname>
<given-names>Suzanne M.E.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O’Driscoll</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gregory-Evans</surname>
<given-names>Cheryl Y.</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rajcan-Separovic</surname>
<given-names>Evica</given-names>
</name>
<email>eseparovic@cw.bc.ca</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Pathology and Laboratory Medicine, University of British Columbia (UBC), Vancouver, British Columbia, Canada.</aff>
<aff id="A2"><label>2</label>Child and Family Research Institute, Vancouver, British Columbia, Canada.</aff>
<aff id="A3"><label>3</label>Human DNA Damage Response Disorders Group, Genome Damage and Stability Centre, University of Sussex, Brighton, United Kingdom.</aff>
<aff id="A4"><label>4</label>University of Texas at Dallas, Dallas, Texas, USA.</aff>
<aff id="A5"><label>5</label>St. Luke’s Children’s Hospital, Boise, Idaho, USA.</aff>
<aff id="A6"><label>6</label>Department of Pathology and Molecular Medicine, McMaster University Medical Centre, Hamilton, Ontario, Canada.</aff>
<aff id="A7"><label>7</label>St. Luke’s Mountain States Tumor Institute, Boise, Idaho, USA.</aff>
<aff id="A8"><label>8</label>Department of Medical Genetics, UBC, Vancouver, British Columbia, Canada.</aff>
<aff id="A9"><label>9</label>Medical Genetics, Université de Sherbrooke, Sherbrooke, Québec, Canada.</aff>
<aff id="A10"><label>10</label>Department of Ophthalmology, UBC, Vancouver, British Columbia, Canada.</aff>
<author-notes>
<corresp>Address correspondence to: Mark O’Driscoll, Human DNA Damage Response Disorders Group, Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9RQ, United Kingdom. Phone: 44.0.1273.877-515; E-mail: <email>m.o-driscoll@sussex.ac.uk</email>. Or to: Cheryl Y. Gregory-Evans, Department of Ophthalmology and Visual Sciences, University of British Columbia, Eye Care Centre, 2550 Willow Street, Vancouver, BC, V5Z 3N9, Canada. Phone: 604.875.5529; E-mail: <email>cge30@mail.ubc.ca</email>. Or to: Evica Rajcan-Separovic, Department of Pathology and Laboratory Medicine, University of British Columbia, Child and Family Research Institute, 950 West 28th, Room 309, Vancouver, BC, V5Z 4H4, Canada. Phone: 604.875.3121; E-mail: <email>eseparovic@cw.bc.ca</email>.</corresp>
<fn>
<p><bold>Authorship note:</bold> H. Bagheri and C. Badduke contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2016-03-17" publication-format="electronic">
<day>17</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2016-03-17" publication-format="electronic">
<day>17</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>3</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 0 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>1</volume>
<issue>3</issue>
<elocation-id>e85461</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>2</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://insight.jci.org/articles/view/85461">This article is available online at https://insight.jci.org/articles/view/85461</self-uri>
<abstract>
<p>The 2p15p16.1 microdeletion syndrome has a core phenotype consisting of intellectual disability, microcephaly, hypotonia, delayed growth, common craniofacial features, and digital anomalies. So far, more than 20 cases of 2p15p16.1 microdeletion syndrome have been reported in the literature; however, the size of the deletions and their breakpoints vary, making it difficult to identify the candidate genes. Recent reports pointed to 4 genes (<italic>XPO1</italic>, <italic>USP34</italic>, <italic>BCL11A</italic>, and <italic>REL</italic>) that were included, alone or in combination, in the smallest deletions causing the syndrome. Here, we describe 8 new patients with the 2p15p16.1 deletion and review all published cases to date. We demonstrate functional deficits for the above 4 candidate genes using patients’ lymphoblast cell lines (LCLs) and knockdown of their orthologs in zebrafish. All genes were dosage sensitive on the basis of reduced protein expression in LCLs. In addition, deletion of <italic>XPO1</italic>, a nuclear exporter, cosegregated with nuclear accumulation of one of its cargo molecules (rpS5) in patients’ LCLs. Other pathways associated with these genes (e.g., NF-κB and Wnt signaling as well as the DNA damage response) were not impaired in patients’ LCLs. Knockdown of <italic>xpo1a</italic>, <italic>rel</italic>, <italic>bcl11aa</italic>, and <italic>bcl11ab</italic> resulted in abnormal zebrafish embryonic development including microcephaly, dysmorphic body, hindered growth, and small fins as well as structural brain abnormalities. Our multifaceted analysis strongly implicates <italic>XPO1</italic>, <italic>REL</italic>, and <italic>BCL11A</italic> as candidate genes for 2p15p16.1 microdeletion syndrome.</p>
</abstract>
<abstract abstract-type="toc">
<p>Multifaceted analysis in patient lymphoblast cell lines and zebrafish implicates <italic>XPO1</italic>, <italic>REL</italic>, and <italic>BCL11A</italic> as candidate genes for the 2p15p16.1 microdeletion syndrome.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>